Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

active_not_recruiting120%
withdrawn120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Mind-Body Intervention in Glioma Couples

NCT03244995
completednot_applicable

Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes

NCT01000623
completednot_applicable

Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy

NCT01901835
withdrawnnot_applicable

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

NCT02166983
completednot_applicable

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

NCT00376818

Clinical Trials (5)

Showing 5 of 5 trials
NCT03244995Not Applicable

Mind-Body Intervention in Glioma Couples

Active Not Recruiting
NCT01000623Not Applicable

Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes

Completed
NCT01901835Not Applicable

Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy

Completed
NCT02166983Not Applicable

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Withdrawn
NCT00376818Not Applicable

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5